NDC 51079-558-01
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51079-558
- Requested NDC
- 51079-558-01
- Package NDCs from labels
- 51079-558-01
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51079-558-01 | EA - Each | 51079-558 | 51c9626b-39ea-4165-8688-e1872a915dd3 | 1 | 2012-07-24 |
| 51079-558-03 | EA - Each | 51079-558 | d21ece36-fa91-4332-afe8-7fd16ef3bf8a | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clopidogrel | CLOPIDOGREL BISULFATE | Westminster Pharmaceuticals, LLC | bb3b5e96-e629-4db5-8ad5-40c17c6dae18 | 2026-09-29 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| CLOPIDOGREL | CLOPIDOGREL BISULFATE | REMEDYREPACK INC. | 669f0bc6-f173-484d-8efe-c006683b25d1 | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | REMEDYREPACK INC. | 2969deac-274b-4042-9c90-9522e62a979d | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
| CLOPIDOGREL | CLOPIDOGREL BISULFATE | Preferred Pharmaceuticals Inc. | c9928956-bb7b-4ec2-bc38-d3c9c4199cae | 2026-07-24 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | REMEDYREPACK INC. | 3e2539c1-a6ad-4d60-944c-c2e7aa70ce45 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL | Redpharm Drug | 55731d95-0c99-ff61-e063-6394a90a1ab5 | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | REMEDYREPACK INC. | e5ee3807-5c9d-4b65-b188-4159a0fb1c85 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
| CLOPIDOGREL | CLOPIDOGREL BISULFATE | Ascend Laboratories, LLC | db1161c9-6efd-4361-a766-6a37c241ccee | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | Cardinal Health 107, LLC | c03a895c-2d74-4d7f-891f-b752ce409b68 | 2026-04-21 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Polyethylene Glycol (3350) | POLYETHYLENE GLYCOL (3350) | Mylan Institutional Inc. | 219bcbc4-b84a-4209-9f34-ef2b0ef0d273 | 2026-04-08 | Warnings | Mylan Institutional Inc. |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | Preferred Pharmaceuticals, Inc. | e51d4bcc-01df-409d-9179-45e6536ac25b | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | Legacy Pharmaceutical Packaging, LLC | 53de10a5-dbd0-413d-90e5-00a1920ec391 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | NuCare Pharmaceuticals,Inc. | 553b4938-4462-4aeb-e054-00144ff88e88 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | NuCare Pharmaceuticals,Inc. | 55530ff3-5ce4-120f-e054-00144ff8d46c | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | NCS HealthCare of KY, LLC dba Vangard Labs | 8406b8e3-e203-402f-8858-2748119e2351 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
| Chlorthalidone | CHLORTHALIDONE | Mylan Institutional Inc. | 193c85ba-43c2-4be2-82cf-7b394a83390e | 2026-01-20 | Warnings, Adverse reactions | Mylan Institutional Inc. |
| Clopidogrel | CLOPIDOGREL BISULFATE | AvPAK | 94a5cdc4-e063-1d46-e053-2995a90a7e15 | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| CLOPIDOGREL | CLOPIDOGREL BISULFATE | Novadoz Pharmaceuticals LLC | 1447a095-c663-4f05-91d4-f09bfc0c3d42 | 2025-11-12 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Levetiracetam | LEVETIRACETAM | Mylan Institutional Inc. | 08e1bfea-7f3f-42d9-823d-f75080e664ff | 2025-11-12 | Warnings, Adverse reactions | Mylan Institutional Inc. |
| Chlordiazepoxide Hydrochloride | CHLORDIAZEPOXIDE HYDROCHLORIDE | Mylan Institutional Inc. | 68c7d8a7-08b3-4a1a-acbd-09bbe67b8d4a | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | Mylan Institutional Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.